ALLOZYNE INC
Biotechnology · Seattle, WA
Data ndekọ gọọmentị
0ndị na-eso
2005tọrọ ntọala
Maka ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
NgalabaBiotechnology
Isi ụlọ ọrụSeattle, WA
Tọrọ ntọala2005
Ụdị iwuC Corporation
ỌnọdụNa-arụ ọrụ
Nyocha
Enweghị nyocha ugbu a. Ị rụrụ ọrụ na ALLOZYNE INC? Bụrụ onye mbụ kekọrịta ahụmahụ gị.
Ọnụọgụ isi
Banye iji hụ ọnụ ọgụgụ ndị isi
Ego mbata, uru net na ọnụ ọgụgụ ndị ọrụ nke ALLOZYNE INC ka afọ na-aga, tinyere isi mmalite ha.
Banye Mepụta akaụntụ site n'ozi-e gịỌ bụ n'efu
Site n'ịga n'ihu, ị na-ekweta Nkwekọrịta onye ojiji, Amụma nzuzo na Amụma kuki nke Heelky.
Ozi iwu
| Aha iwu | ALLOZYNE INC |
|---|---|
| Ụdị iwu | C Corporation |
| SEC CIK | 1345630Lee na SEC EDGAR ↗ |
| Adreesị edebanyere aha | Seattle, WA |
| Ọnọdụ | Na-arụ ọrụ |
Isi mmalite: SEC EDGAR · emelitere 14 Nọvemba 2026
Kọntaktị & njikọ
Ebe
Seattle, WA
Nke a ọ bụ ụlọ ọrụ gị?
Kwuo ibe a n'efu iji tinye logo gị, ngwaahịa, foto na ọrụ, na iza nyocha.
Kwuo ibe aSonye na Heelky iji jikọọ, were ndị ọrụ ma too
Mepụta akaụntụ efu iji zipụ ndị mmadụ ozi, tinye arịrịọ ọrụ ma bipụta mishọn.
Sonye ugbu a — ọ bụ n'efu